SBFC Finance Q3 Financials Show Strong Growth in FY26

SBFC Finance has announced its unaudited financial results for Q3 FY26, reporting a net profit of ₹1,180.40 million. The company’s total revenue from operations reached ₹4,255.66 million. The gross NPA stands at 2.71%. The results showcase sustained growth and operational efficiency for the quarter ended December 31, 2025.

Financial Performance

SBFC Finance reported a net profit of ₹1,180.40 million for Q3 FY26, compared to ₹880.78 million in the corresponding quarter of the previous year. The total income for the quarter was ₹4,258.14 million.

For the nine months ended December 31, 2025, the company’s net profit stood at ₹3,280.66 million, with total income at ₹12,253.60 million.

Key Financial Metrics

Key financial ratios as of December 31, 2025, include:

  • Debt-equity ratio: 1.97 times
  • Gross Non-Performing Assets (GNPA): 2.71%
  • Net Non-Performing Assets (NNPA): 1.48%
  • Provision coverage ratio: 46.21%
  • Capital to risk-weighted assets ratio: 31.70%

Operational Highlights

The company’s revenue from operations for Q3 FY26 was ₹4,255.66 million, including ₹3,973.09 million from interest income. Impairment on financial instruments was reported at ₹326.74 million for the quarter.

SBFC Finance has also disclosed details of stressed loans transferred to ARCs, with an aggregate principal outstanding of ₹632.40 million across 911 accounts.

Security Cover

The company maintains sufficient security cover in respect of the secured listed non-convertible debentures. The security cover certificate as of December 31, 2025, is enclosed with the announcement. The Company has maintained 1.10x asset cover.

Utilization of Issue Proceeds

There has been no deviation in the use of proceeds from Non-Convertible Debentures during Q3 FY26. The funds are being utilized for on-lending to secured micro, small, and medium enterprises and gold loans.

Source: BSE

Previous Article

Kotak Mahindra Bank Board Approves Proposal to Raise Funds via Debentures

Next Article

Torrent Pharmaceuticals Increases Stake in J.B. Chemicals via Employee Share Purchase